Literature DB >> 8645607

Dual regulation of the epidermal growth factor family of growth factors in breast cancer by sex steroids and protein kinase C.

I Martinez-Lacaci1, R B Dickson.   

Abstract

There has been increased interest in the last few years in seeking a better understanding of the local regulation of polypeptide growth factors by systemic hormones, such as sex steroids and by polypeptide hormones. Growth factors and systemic hormones play pivotal roles in hormone-regulated cancers such as breast cancer. In this review, we discuss the regulation of members of the epidermal growth factor (EGF) family by sex steroids and by regulators of the polypeptide hormone signal transduction enzyme termed protein kinase C (PKC). Regulation of the EGF family of genes will be discussed as a model system to evaluate interactions between these two important types of regulatory pathways in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645607     DOI: 10.1016/0960-0760(95)00245-6

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  High-throughput sample preparation and analysis using 96-well membrane solid-phase extraction and liquid chromatography-tandem mass spectrometry for the determination of steroids in human urine.

Authors:  G Rule; J Henion
Journal:  J Am Soc Mass Spectrom       Date:  1999-12       Impact factor: 3.109

2.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

3.  Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells.

Authors:  G Vani; C S Shyamala Devi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

4.  Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line.

Authors:  V Go; J Garey; M S Wolff; B G Pogo
Journal:  Environ Health Perspect       Date:  1999-03       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.